Skip to main content

Peer Review reports

From: Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer

Original Submission
22 Jun 2021 Submitted Original manuscript
21 Dec 2021 Reviewed Reviewer Report
19 Jan 2022 Reviewed Reviewer Report
10 Feb 2022 Author responded Author comments - Maarten F. Bijlsma
24 Feb 2022 Author responded Author comments - Maarten F. Bijlsma
Resubmission - Version 2
10 Feb 2022 Submitted Manuscript version 2
2 Mar 2022 Author responded Author comments - Maarten F. Bijlsma
Resubmission - Version 3
2 Mar 2022 Submitted Manuscript version 3
9 Mar 2022 Reviewed Reviewer Report
15 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
21 Mar 2022 Editorially accepted
12 Apr 2022 Article published 10.1186/s12885-022-09436-0

You can find further information about peer review here.

Back to article page